According to market research, the global animal health market was valued at approximately $139 billion in 2020 and is predicted to grow to more than $190 billion by 2027. Even without its projected growth, animal health organizations, much like their human pharmaceutical counterparts, often do not have the adequate technology infrastructure to support or streamline […]
Posts Tagged ‘adverse events’
Training Multiple AI Models for Life Sciences Use Case
–Prabha Ranganathan and Ruby Lin contributed to this blog. Understanding how AI/ML can be used for innovative life sciences-related use cases is an area our industry lags. In this blog post, we’ll discuss several use cases in which unique AI models can be used to resolve critical issues effectively: NLQ (Natural Language Querying) – We […]
Aggregate Report Preparation In Safety And Pharmacovigilance
Aggregate report preparation represents one of the single most time- and resource-intensive pharmacovigilance regulatory requirements, which is why many companies are interested in more automated solutions that are fit-for-purpose. What we typically recommend to clients is a focused approach that optimizes as much as their internal workflow as possible. We also recommend that subject matter […]
Top 5 Pharma & Medical Device Blog Posts From June 2017
Now that July is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in June – they’re ranked in order of popularity, with number one being the most viewed piece. What Exactly Is An “Adverse […]
[This Week] Mining The Internet For Safety Signals
Online communities and social networks like Twitter and Facebook have become important real-world data repositories that can be leveraged by life sciences organizations to gain insight into the patient experience, as well as to identify potential safety issues related to drugs and devices – otherwise known as safety signal detection. This week, my colleague, Dr. […]
Will We See More Advertising From Pharma On Facebook?
Bayer recently launched its first Facebook ad. The ad also happens to be the first time Facebook has allowed a company to put important safety information (ISI) in a scrolling format, something that pharmaceutical companies have long been able to do in banner ads. In addition, the social media giant is also enabling drug companies […]
FDA Director: We’re Watching How You Manage Product Complaints
We frequently blog about FDA Warning Letters and other regulatory and compliance issues that revolve around traditional pharmaceuticals and medical devices. However, one product segment that we haven’t yet discussed is digital health. This is because digital health products are fairly new to the market and most are still trying to figure out how FDA […]
The Next Best Thing To A Private Demo Of Argus Safety 8.x
Bring out the popcorn! This Thursday, Dr. Rodney Lemery, one of our experts in drug safety and pharmacovigilance, will be delivering a webinar on the latest version of Oracle Argus Safety, the most widely used and trusted PV system on the market. This presentation is meant for everyone, whether you’re already using the system and […]
Trending: Investing In Social Listening Tools
It’s not easy to sift through and make sense of the vast amount of data posted each day by patients or their caregivers via social media. When it comes to unstructured data (e.g., abbreviations and acronyms), it’s even more difficult. However, it’s critical to evaluate the constant chatter to help detect or prevent possible issues, […]
How Bad Data In FAERS Wreaked Havoc On Regeneron
An interesting thing happened in pharma and investing. It involved Regeneron and their July 24, 2015 FDA-approved cholesterol drug, Praluent. Forbes outlined the situation, which caused Regeneron stock to drop significantly, in a January 6, 2016 article. According to Matthew Herper, a Forbes columnist, investors got a hold of data from the FDA’s Adverse […]
Good Chance Your Doctor Doesn’t Know Your Med’s Real Indication
This is bizarre. It turns out that many doctors don’t know what the real, FDA-approved indications are for the medications they’re prescribing. In a Wall Street Journal article that discusses the risks of off-label uses for prescription drugs, the author cites a 2009 study of 1,199 physicians (mostly primary care doctors and psychiatrists) that […]
U.S. Military Keeping A Close Eye On Supplements
Megan Thielking from Stat News reports that a scientific journal took a close look at the impact nutritional supplements are having on U.S. military personnel. According to the article, 75% of people in the U.S. military take some type of dietary supplement every month. Since dietary supplements, such as weight-loss pills and multivitamins, don’t […]